Concepedia

Sequence Liability Analysis

Sequence Liability Analysis is a computational assessment method used in developability evaluation to identify and characterize sequence-derived structural and biophysical liabilities that may compromise the stability, expressibility, or immunogenicity of protein therapeutics.

0

Publications

0

Citations

0

Authors

0

Institutions

Parents

Publications

0

1–1 of 0

Authors

0

  1. TK
    Tomasz Klaus

    Jagiellonian University, Poland

    1 publications · 11 citations

    0

    h-index

  2. AK
    Anna Kostyn

    AGH University of Krakow, Poland

    1 publications · 11 citations

    0

    h-index

  3. SK
    Sandeep Kumar

    Indian Institute of Technology Roorkee, India

    1 publications · 11 citations

    0

    h-index

  4. AB
    Andrew Buchanan

    AstraZeneca (United Kingdom), United Kingdom

    1 publications · 11 citations

    0

    h-index

  5. TS
    Tadeusz Satława

    Pure Biologics (Poland), Poland

    1 publications · 11 citations

    0

    h-index

1–5 of 0

Institutions

0

  1. AGH University of Krakow

    Krakow, Poland

    1 publications

    11 citations

  2. Moderna Therapeutics (United States)

    Cambridge, United States

    1 publications

    11 citations

  3. Wrocław University of Science and Technology

    Wroclaw, Poland

    1 publications

    11 citations

  4. Pure Biologics (Poland)

    Wrocław, Poland

    1 publications

    11 citations

  5. AstraZeneca (United Kingdom)

    Cambridge, United Kingdom

    1 publications

    11 citations

1–5 of 0

Venues

  1. PLoS Computational Biology

    1 publications · 11 citations

1–1